|
[1] BONZI M,FIORELLI EM,Gruppo di Autoformazione Metodologica(Gr AM). Indomethacin prevents post-ERCP pancreatitis in selected high-risk patients[J]. Intern Emerg Med,2012,7(6):557-558.
|
|
[2] FRANK CD,ADLER DG. Post-ERCP pancreatitis and its prevention[J]. Nat Clin Pract Gastroenterol Hepatol,2006,3(12):680-688.
|
|
[3] DUMONCEAU JM,KAPRAL C,AABAKKEN L,et al. ERCPrelated adverse events:European Society of Gastrointestinal Endoscopy(ESGE)Guideline[J]. Endoscopy,2020,52(2):127-149.
|
|
[4] BAI Y,LI F,WANG SL,et al. Chinese expert consensus on perioperative medications for endoscopic retrograde cholangiopancreatography(ERCP)[J]. J Dig Dis,2019,20(3):103-113.
|
|
[5] PEKGZ M. Post-endoscopic retrograde cholangiopancreatography pancreatitis:A systematic review for prevention and treatment[J]. World J Gastroenterol,2019,25(29):4019-4042.
|
|
[6] MENG W,LEUNG JW,ZHANG K,et al. Optimal dilation time for combined small endoscopic sphincterotomy and balloon dilation for common bile duct stones:A multicentre,singleblinded,randomised controlled trial[J]. Lancet Gastroenterol Hepatol,2019,4(6):425-434.
|
|
[7] LIU ZY,CHEN CM,HOU HY,et al. Towards an epoch of great changes of science studies[J]. Sci Sci Manag S T,2009,30(7):5-12.(in Chinese)刘则渊，陈超美，侯海燕，等．迈向科学学大变革的时代[J]．科学学与科学技术管理，2009,30(7):5-12.
|
|
[8] SHI JY,WU T,YANG J,et al. Mapping knowledge domains analysis of transfusion medicine research based on Cite SpaceⅢ[J]. J Mod Lab Med,2015,30(3):24-27,31.(in Chinese)史纪元，吴涛，杨筠，等．基于Cite SpaceⅢ输血医学研究领域知识图谱分析[J]．现代检验医学杂志，2015,30(3):24-27,31.
|
|
[9] CHEN C. Cite Space II:Detecting and visualizing emerging trends and transient patterns in scientific literature[J]. J Am Soc Inf Sci Tec,2006,57(3):359-377.
|
|
[10] Derek John de Solla Price. Little Science,Big Science[M].Translated by Song Jiangeng,Dai Zhenfei. Beijing:International Science Organization,1982:39-42.(in Chinese)D．普赖斯．小科学，大科学[M]．宋剑耕，戴振飞，译．北京:世界科学社，1982:39-42.
|
|
[11] WANG SB,CHEN ZJ,CHENG YJ,et al. Mapping knowledge domain analasis on treatment of type 2 diabetes mellitus by traditional Chinese medicine[J]. Chin Arch Tradit Chin Med,2016,34(9):2082-2087.(in Chinese)王淑斌，陈子杰，程玉娟，等．中医药治疗2型糖尿病知识图谱分析[J]．中华中医药学刊，2016,34(9):2082-2087.
|
|
[12] QIU JP,ZHANG XP. Author co-citation analysis of knowledge management in China based on the CSSCI[J]. Inf Sci,2011,29(10):1441-1445.(in Chinese)邱均平，张晓培．基于CSSCI的国内知识管理领域作者共被引分析[J]．情报科学，2011,29(10):1441-1445.
|
|
[13] ZHANG XT. Analysis on the research hotspots of nationwide reading through the SNA[J]. J Lib Inf Sci Agric,2016,28(6):80-84.(in Chinese)章小童．基于社会网络分析法的全民阅读研究热点探析[J]．农业图书情报学刊，2016,28(6):80-84.
|
|
[14] ELMUNZER BJ,SCHEIMAN JM,LEHMAN GA,et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis[J]. N Engl J Med,2012,366(15):1414-1422.
|
|
[15] DUMONCEAU JM,ANDRIULLI A,ELMUNZER BJ,et al. Prophylaxis of post-ERCP pancreatitis:European Society of Gastrointestinal Endoscopy(ESGE)Guideline-updated June 2014[J].Endoscopy,2014,46(9):799-815.
|
|
[16] ANDERSON MA,FISHER L,JAIN R,et al. Complications of ERCP[J]. Gastrointest Endosc,2012,75(3):467-473.
|
|
[17] COTTON PB,EISEN GM,AABAKKEN L,et al. A lexicon for endoscopic adverse events:Report of an ASGE workshop[J]. Gastrointest Endosc,2010,71(3):446-454.
|
|
[18] BANKS PA,BOLLEN TL,DERVENIS C,et al. Classification of acute pancreatitis—2012:Revision of the Atlanta classification and definitions by international consensus[J]. Gut,2013,62(1):102-111.
|
|
[19] COTTON PB,GARROW DA,GALLAGHER J,et al. Risk factors for complications after ERCP:A multivariate analysis of11,497 procedures over 12 years[J]. Gastrointest Endosc,2009,70(1):80-88.
|
|
[20] Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis[J]. Pancreatology,2013,13(4 Suppl 2):e1-e15.
|
|
[21] TESTONI PA,MARIANI A,GIUSSANI A,et al. Risk factors for post-ERCP pancreatitis in high-and low-volume centers and among expert and non-expert operators:A prospective multicenter study[J]. Am J Gastroenterol,2010,105(8):1753-1761.
|
|
[22] ASGE Standards of Practice Committee,MAPLE JT,BENMENACHEM T,et al. The role of endoscopy in the evaluation of suspected choledocholithiasis[J]. Gastrointest Endosc,2010,71(1):1-9.
|
|
[23] CHOUDHARY A,BECHTOLD ML,ARIF M,et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis:A meta-analysis and systematic review[J]. Gastrointest Endosc,2011,73(2):275-282.
|
|
[24] KHOSHBATEN M,KHORRAM H,MADAD L,et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis[J]. J Gastroenterol Hepatol,2008,23(7 Pt 2):e11-e16.
|
|
[25] ELMUNZER BJ,WALJEE AK,ELTA GH,et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis[J]. Gut,2008,57(9):1262-1267.
|
|
[26] AKSHINTALA VS,HUTFLESS SM,COLANTUONI E,et al.Systematic review with network meta-analysis:Pharmacological prophylaxis against post-ERCP pancreatitis[J]. Aliment Pharmacol Ther,2013,38(11-12):1325-1337.
|
|
[27] ELMUNZER BJ,HIGGINS PD,SAINI SD,et al. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data[J]. Am J Gastroenterol,2013,108(3):410-415.
|
|
[28] LUO H,ZHAO L,LEUNG J,et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography:A multicentre,single-blinded, randomised controlled trial[J]. Lancet,2016,387(10035):2293-2301.
|
|
[29] LEVENICK JM,GORDON SR,FADDEN LL,et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients[J]. Gastroenterology,2016,150(4):911-917.
|
|
[30] MENES T,SPIVAK H. Laparoscopy:Searching for the proper insufflation gas[J]. Surg Endosc,2000,14(11):1050-1056.
|
|
[31] COSTAMAGNA G,SHAH SK,TRINGALI A. Current management of postoperative complications and benign biliary strictures[J].Gastrointest Endosc Clin N Am,2003,13(4):635-648.
|
|
[32] JIMNEZ-ROMERO C,MANRIQUE A,GARCA-CONDE M,et al. Biliary complications after liver transplantation from uncontrolled donors after circulatory death:Incidence,management,and outcome[J]. Liver Transpl,2020,26(1):80-91.
|
|
[33] WANG Q,MOON SB,ZANG J,et al. Usefulness of pre-operative endoscopic retrograde cholangiopancreatography in diagnosis and management of forme fruste choledochal cyst in children[J]. ANZ J Surg,2020.[Online ahead of print]
|
|
[34] FURUKAWA K,ONDA S,HAMURA R,et al. Predictive factors and surgical outcomes of stent dysfunction after preoperative endoscopic biliary stenting in patients who underwent pancreaticoduodenectomy[J]. J Laparoendosc Adv Surg Tech A,2020,30(3):256-259.
|
|
[35] CHENG LL,TANG CF,ZHAO JH,et al. Recent advances in digestive endoscopy in the field of pancreaticobiliary diseases[J]. J Clin Hepatol,2019,35(1):222-225.(in Chinese)程里礼，唐超峰，赵继航，等．消化内镜技术在胆胰领域的应用现状[J]．临床肝胆病杂志，2019,35(1):222-225.
|
|
[36] ZHOU HX,DONG XY,BU P,et al. Application of endoscopic retrograde cholangiopancreatography in treatment of extrahepatic biliary adenoma[J]. J Clin Hepatol,2016,32(12):2353-2355.(in Chinese)周海祥，董小耘，卜平，等．经内镜逆行胰胆管造影在肝外胆管腺瘤诊治中的应用[J]．临床肝胆病杂志，2016,32(12):2353-2355.
|
|
[37] WANG ZC. Curative effect of ERCP on senile patients with choledocholithiasis and its effect on serum inflammatory factors[J]. Trauma and Crit Medicine,2019,7(4):233-235.(in Chinese)王智超．内镜下逆行胆胰管造影术对老年胆总管结石患者疗效研究[J]．创伤与急危重病医学，2019,7(4):233-235.
|
|
[38] GUO XG. Reconsideration and thoughts of endoscopic retrograde cholangiopancreatography in China[J]. Chin J Dig Endosc,2016,33(5):273-276.(in Chinese)郭学刚．中国ERCP再认识和思考[J]．中华消化内镜杂志，2016,33(5):273-276.
|
|
[39] COLTON JB,CURRAN CC. Quality indicators,including complications,of ERCP in a community setting:A prospective study[J]. Gastrointest Endosc,2009,70(3):457-467.
|
|
[40] WILLIAMS EJ,TAYLOR S,FAIRCLOUGH P,et al. Risk factors for complication following ERCP; results of a largescale,prospective multicenter study[J]. Endoscopy,2007,39(9):793-801.
|
DownLoad: